![](/img/cover-not-exists.png)
A prospective, randomized placebo-controlled multicenter trial evaluating fenoldopam mesylate for the prevention of contrast induced nephropathy: The CONTRAST trial
Gregg W. Stone, Peter McCullough, James Tumlin, Hooman Madyoon, Patrick Murray, Andrew Wang, A. Alan Chu, Gary Schaer, Melissa Stevens, Robert L. Wilensky, William W. O'Neill, Norman LeporVolume:
41
Year:
2003
Language:
english
DOI:
10.1016/s0735-1097(03)80973-7
File:
PDF, 310 KB
english, 2003